10.1016/s1470-2045(15)00139-4 - Cediranib or placebo in combination w...

This document has been corrected

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

10.1016/s1470-2045(15)00139-4

Published Online: 2015-08-?

Journal: The Lancet Oncology•Publisher: Elsevier BV

Authors: Alison C Backen•Andre Lopes•Anthony Maraveyas•Caroline Dive•Charlotte Rees•D Alan Anthoney•Daniel H Palmer•David Cunningham•Harpreet Wasan•John A Bridgewater•Juan W Valle•Justin S Waters•Karen Morris•Marian Duggan•Paul J Ross•Pippa Corrie•Sandy Beare•Srinivasan Madhusudan•Will P Steward

This document has been corrected

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

10.1016/s1470-2045(15)00139-4

Published Online: 2015-08-?

Journal: The Lancet Oncology

NOW

2015-09-01•Erratum

Correction to Lancet Oncol 2015; 16: 967–78

10.1016/s1470-2045(15)00239-9

* information provided by CrossRef

2015-09-01•Erratum

10.1016/s1470-2045(15)00239-9

* information provided by CrossRef

2015-08-?•Published

2015-09-01•Erratum

Correction to Lancet Oncol 2015; 16: 967–78

10.1016/s1470-2045(15)00239-9

* information provided by CrossRef

This document has been corrected

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

10.1016/s1470-2045(15)00139-4

Published Online: 2015-08-?

Journal: The Lancet Oncology•Publisher: Elsevier BV